Startup · $108m raised · Healthcare
Medtech company providing advanced patient monitoring and diagnostics
Melbourne, VIC
Programs: LaunchVic (30×30)
Every investor coverage indicates participated in a round Seer Medical raised.
| Investor | Rounds | Invested |
|---|---|---|
| TrialCap | Unnamed stage | - |
| SG Hiscock | Series A | - |
| Medtech Actuator | Accelerator | - |
| LaunchVic | Accelerator | - |
| Giant Leap | Series A | - |
| EWM Group | Series A | - |
| Cochlear | Series A | - |
| Cadwell Industries | Unnamed stage | - |
| Breakthrough Victoria | Unnamed stage · Venture debt · Unnamed stage | $34,000,000 |
| Austrade | Accelerator | - |
Every published round Seer Medical took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| EpiMinder | Bridge / extension | 21 Mar 2022 | $16m | Participant | Startup Daily (2 Dec 2025), Startup Daily (21 Mar 2022), @AuManufacturing, Startup Daily (15 Mar 2022) |
Companies Seer Medical has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| EpiMinder | Maker of a continuous seizure monitoring system for epilepsy | 21 Mar 2022, Bridge / extension | 1 | 0 |
Fund closes reported for Seer Medical, as distinct from the investments it has made.
Companies Seer Medical has backed that another company then bought. An exit for the holding, not a deal Seer Medical did.
| Company | Bought by | Kind | Announced | Price |
|---|---|---|---|---|
| No portfolio company of Seer Medical is recorded as having been acquired. | ||||
Companies Seer Medical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Dean Freestone | CEO (former) · Founder | Startup Daily (17 Apr 2025), SmartCompany (17 Apr 2025), Startup Daily (11 Feb 2025), Startup Daily (28 Jan 2025), Startup Daily (7 Jan 2025), Startup Daily (20 Dec 2024), SmartCompany (23 Nov 2022), Breakthrough Victoria |
| Dr Pip Karoly | Data Scientist | SmartCompany (17 Apr 2025), SmartCompany (23 Nov 2022) |
| George Kenley | Co-founder and COO (former) | ANDHealth, SmartCompany (17 Apr 2025), Startup Daily, SmartCompany (23 Nov 2022) |
| Professor Mark Cook | Founder | SmartCompany (17 Apr 2025), Startup Daily, SmartCompany (23 Nov 2022) |
Stories naming Seer Medical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Victoria's opposition pledges to shut down Breakthrough Victoria and sell its investments, calling the state fund a failure. The piece recalls portfolio raises, a rescue deal, an NYSE listing and the LaunchVic merger.
AndHealth has appointed Seer Medical's co-founder and former COO George Kenley as its 2026 ACTIVATE Executive in Residence; she will mentor Victorian digital health startups, with applications due 22 March.
ANDHealth appoints Anne O'Neill and George Kenley to senior leadership roles while outgoing COO Grace Lethlean departs after nine years.
Administrators confirmed a $40 million deal in which Cadwell Industries, TrialCap and Breakthrough Victoria take equity, rescuing Seer Medical from administration; the article also recalls its funding history and 2024 product recall.
Breakthrough Victoria, the Victorian government's $2bn investment fund, appoints Rod Bristow, previously Investible's CEO, as chief executive, succeeding inaugural CEO Grant Dooley. The article also recalls Seer Medical's administration.
Victorian epilepsy device maker Seer Medical has entered voluntary administration, with Pitcher Partners appointed amid a product recall and a cofounder's legal dispute; backers included Breakthrough Victoria and Cochlear.
Seer Medical's cofounder is suing the startup and investor Breakthrough Victoria over his dismissal, allegedly tied to rescue funding; the state fund also faces criticism, budget cuts and its CEO's resignation.
The Victorian government's VC fund Breakthrough Victoria slipped to a loss, its annual report showing startup investments, cost cutting and boardroom departures amid criticism of its spending and performance.
Breakthrough Victoria reflects on its third annual report: over $350 million committed across 44 investments, including five follow-on investments worth over $35 million in the past financial year across five named portfolio companies.
Breakthrough Victoria defends its spending and investment record against critics urging its abolition, pointing to portfolio companies, university partnerships and recent backing of startups including Aravax.
Breakthrough Victoria's media release marks three years, citing more than $300 million committed across direct investments, a fund, a grant and university partnerships, and discusses its Aravax and Seer Medical investments.
AI search startup Marqo has landed a $12.5 million Series A and is relocating its headquarters to San Francisco, while LaunchVic statistics show Victoria's ecosystem grew in value despite a funding drop.
MedTech Actuator alumni are behind Synthesis Capital, a new venture fund courting investors for up to $100m to back young health technology companies across Australia and the Asia-Pacific.
LaunchVic reopens expressions of interest for its 30×30 program aiming to create 30 Victorian unicorns by 2030, recalling last year's nine participants, while July appoints Joanne Smith as its first chief financial officer.
Breakthrough Victoria's chief executive reviews the investment firm's first operating year, recalling backing for several startups, a university pre-seed fund platform, a quantum technology facility, and a new environmental challenge program.
Seer Medical founding member Dr Pip Karoly won a 2022 Prime Minister's Prize for New Innovators for seizure forecasting research; the medtech has raised over $80 million to date.
Victoria granted $900,000 across three new angel networks to back early-stage startups, while LaunchVic grant recipient Archangel Ventures has launched a $25 million venture capital fund.
Breakthrough Victoria announces an investment in Seer Medical, a Victorian epilepsy home-monitoring medtech, to fund workforce growth, R&D and expansion into the United States and United Kingdom.
Also Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily
Epiminder raised A$18 million in bridge funding for its epilepsy monitoring implant, backed by existing shareholders including Cochlear, after completing an A$18 million Series A in October 2021.
Epi-Minder has completed a $16 million bridge round with its existing shareholders to fund expanded clinical trials, product development and manufacturing of its long-term epilepsy monitoring device.
Ignition Lane's weekly technology roundup: climate-tech funding activity, Grok's bid for AGL, King River Capital's digital asset fund, a batch of Australian startup raises, Maropost acquisitions, GigSuper's collapse and a National AI Centre appointment.